Cargando…

Distinguishing Amyloid β-Protein in a Mouse Model of Alzheimer’s Disease by Label-Free Vibrational Imaging

Due to the increase in the average age of humans, Alzheimer’s disease (AD) has become one of the disorders with the highest incidence worldwide. Abnormal amyloid β protein (Aβ) accumulation is believed to be the most common cause of AD. Therefore, distinguishing the lesion areas can provide clues fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shaowei, Luo, Ziyi, Zhang, Renlong, Xu, Hao, Zhou, Ting, Liu, Liwei, Qu, Junle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533730/ https://www.ncbi.nlm.nih.gov/pubmed/34677321 http://dx.doi.org/10.3390/bios11100365

Ejemplares similares

Synergistic photobiomodulation with 808-nm and 1064-nm lasers to reduce the β-amyloid neurotoxicity in the in vitro Alzheimer's disease models
por: Zhang, Renlong, et al.
Publicado: (2022)

Long-Term Repeatable In Vivo Monitoring of Amyloid-β Plaques and Vessels in Alzheimer’s Disease Mouse Model with Combined TPEF/CARS Microscopy
por: Luo, Ziyi, et al.
Publicado: (2022)

Optical Imaging of Beta-Amyloid Plaques in Alzheimer’s Disease
por: Luo, Ziyi, et al.
Publicado: (2021)

Label-free multiphoton imaging of β-amyloid plaques in Alzheimer’s disease mouse models
por: Wang, Shu, et al.
Publicado: (2019)

Near-infrared light reduces β-amyloid-stimulated microglial toxicity and enhances survival of neurons: mechanisms of light therapy for Alzheimer’s disease
por: Stepanov, Yurii V., et al.
Publicado: (2022)

The Mechanisms and Efficacy of Photobiomodulation Therapy for Arthritis: A Comprehensive Review
por: Zhang, Renlong, et al.
Publicado: (2023)

Label-free whole-colony imaging and metabolic analysis of metastatic pancreatic cancer by an autoregulating flexible optical system
por: Shen, Binglin, et al.
Publicado: (2020)

Label-free vibrational imaging of different Aβ plaque types in Alzheimer’s disease reveals sequential events in plaque development
por: Röhr, Dominik, et al.
Publicado: (2020)

Label-free imaging of amyloid plaques in Alzheimer’s disease with stimulated Raman scattering microscopy
por: Ji, Minbiao, et al.
Publicado: (2018)

Super-resolution label-free volumetric vibrational imaging
por: Qian, Chenxi, et al.
Publicado: (2021)

Plasma Amyloid Concentration in Alzheimer’s Disease: Performance of a High-Throughput Amyloid Assay in Distinguishing Alzheimer’s Disease Cases from Controls
por: Feinkohl, Insa, et al.
Publicado: (2020)

Graphene based electrochemical immunosensor for the ultra-sensitive label free detection of Alzheimer's beta amyloid peptides Aβ(1–42)
por: Abbasi, Hina. Y., et al.
Publicado: (2021)

Amyloid β and free heme: bloody new insights into the pathogenesis of Alzheimer’s disease
por: Flemmig, Jörg, et al.
Publicado: (2018)

AMPA-ergic regulation of amyloid-β levels in an Alzheimer’s disease mouse model
por: Hettinger, Jane C., et al.
Publicado: (2018)

Characterization of a Novel Mouse Model of Alzheimer’s Disease—Amyloid Pathology and Unique β-Amyloid Oligomer Profile
por: Liu, Peng, et al.
Publicado: (2015)

Klotho overexpression improves amyloid‐β clearance and cognition in the APP/PS1 mouse model of Alzheimer's disease
por: Zhao, Yue, et al.
Publicado: (2020)

Glitter in the Darkness? Nonfibrillar β-Amyloid Plaque Components Significantly Impact the β-Amyloid PET Signal in Mouse Models of Alzheimer Disease
por: Biechele, Gloria, et al.
Publicado: (2022)

β-Amyloid Degradation and Alzheimer's Disease
por: Wang, Deng-Shun, et al.
Publicado: (2006)

Mitochondria, Amyloid β, and Alzheimer's Disease
por: Readnower, Ryan D., et al.
Publicado: (2011)

The Amyloid-β Pathway in Alzheimer’s Disease
por: Hampel, Harald, et al.
Publicado: (2021)

Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration
por: Lim, Chu Hsien, et al.
Publicado: (2020)

Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
por: Song, Chenghuan, et al.
Publicado: (2022)

Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
por: Paris, Daniel, et al.
Publicado: (2010)

Progranulin Protects against Amyloid β Deposition and Toxicity in Alzheimer’s Disease Mouse Models
por: Minami, S. Sakura, et al.
Publicado: (2014)

Correlations of amyloid-β concentrations between CSF and plasma in acute Alzheimer mouse model
por: Cho, Soo Min, et al.
Publicado: (2014)

Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer’s disease
por: Zhao, Ruohe, et al.
Publicado: (2017)

Baicalein reduces β-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer’s disease transgenic mouse model
por: Zhang, She-Qing, et al.
Publicado: (2013)

Human tau increases amyloid β plaque size but not amyloid β‐mediated synapse loss in a novel mouse model of Alzheimer's disease
por: Jackson, Rosemary J., et al.
Publicado: (2016)

β-amyloid binds to microglia Dectin-1 to induce inflammatory response in the pathogenesis of Alzheimer's disease
por: Zhao, Xia, et al.
Publicado: (2023)

The Role of Fluoxetine in Activating Wnt/β-Catenin Signaling and Repressing β-Amyloid Production in an Alzheimer Mouse Model
por: Huang, Min, et al.
Publicado: (2018)

Bioinspired Synthesis of ZnO@polydopamine/Au for Label-Free Photoelectrochemical Immunoassay of Amyloid-β Protein
por: He, Guangli, et al.
Publicado: (2021)

Label-free hyperspectral imaging and deep-learning prediction of retinal amyloid β-protein and phosphorylated tau
por: Du, Xiaoxi, et al.
Publicado: (2022)

Polymorphic Structures of Alzheimer's β-Amyloid Globulomers
por: Yu, Xiang, et al.
Publicado: (2011)

Amyloid β-protein oligomers and Alzheimer’s disease
por: Hayden, Eric Y, et al.
Publicado: (2013)

β-Amyloid oligomers in aging and Alzheimer’s disease
por: Zahs, Kathleen R., et al.
Publicado: (2013)

Magnetoelectric dissociation of Alzheimer’s β-amyloid aggregates
por: Jang, Jinhyeong, et al.
Publicado: (2022)

Anti-Amyloid-β-Mediated Positron Emission Tomography Imaging in Alzheimer's Disease Mouse Brains
por: McLean, Daniel, et al.
Publicado: (2012)

Titration of biologically active amyloid–β seeds in a transgenic mouse model of Alzheimer's disease
por: Morales, Rodrigo, et al.
Publicado: (2015)

Rapid in vivo measurement of β-amyloid reveals biphasic clearance kinetics in an Alzheimer’s mouse model
por: Yuede, Carla M., et al.
Publicado: (2016)

Heterogeneous Association of Alzheimer’s Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses
por: Willén, Katarina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nep1843h5dc0uu50ku6k3fkvg3